Founded in 2017, Panacea Venture invests in and incubates early-stage life science companies with breakthrough technologies and discoveries in the healthcare sector. With offices in Shanghai, Hong Kong, and Silicon Valley, the firm manages three USD funds and one RMB fund. Its investment team members are located across China, the U.S., and Europe, providing extensive coverage of major global life sciences hubs. Panacea Venture aims to address unmet medical needs and enhance the quality of life on a global scale by supporting R&D and innovative companies in the field of life sciences.